Mesenchymal Stem Cells (MSCs) and Thyroid Gland

Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be found in many tissues throughout the body, including the bone marrow, adipose tissue, and even the thyroid gland. MSCs are unique in that they have the ability to self-renew and differentiate into a variety of different cell types, including osteoblasts, chondrocytes, and adipocytes. Additionally, MSCs can be induced to differentiate into more specialized cell types, such as neurons and hepatocytes. The potential for MSCs to be used in the treatment of thyroid diseases is vast. MSCs can be used to replace lost or damaged thyroid cells, as well as to deliver therapeutic agents directly to the site of the disease. Additionally, MSCs can be used to modulate the immune response, which is often dysregulated in thyroid diseases. There are currently several clinical trials underway that are investigating the use of MSCs in the treatment of thyroid diseases. One trial is looking at the use of MSCs to treat Graves' disease, an autoimmune disorder that results in the overproduction of thyroid hormones. Another trial is investigating the use of MSCs to treat Hashimoto's disease, a condition that results in the destruction of the thyroid gland. The use of MSCs in the treatment of thyroid diseases is a promising area of research with the potential to provide new and effective treatments for these conditions.

 "Stem Cell Therapy for Thyroid Diseases: Progress and Challenges." 5 Mar. 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968462/

 "Therapeutic effect of mesenchymal stem cell on Hashimoto's ...." https://pubmed.ncbi.nlm.nih.gov/31793369/

 "Stem Cell Therapy for Thyroid Diseases: Progress and Challenges." https://www.sciencedirect.com/science/article/pii/S0011393X22000042

The information below is the recommended stem cell therapy protocol for this condition 

Route of AdministrationDoseTime (Days)Total Cells
IV50,000,0003150,000,000
Perithyroid50,000,0002100,000,000
Myers cocktail/NAD1N/A
Total250,000,000